Text and Data Mining valid from 2020-03-19
Received: 24 October 2019
Accepted: 5 March 2020
First Online: 19 March 2020
Ethics approval and consent to participate
: The TRANSIT-Stroke Network and data acquisition has been approved by the Ethic Committee of the University of Würzburg (54/14) and was registered in the German Registry for Clinical Studies (DRKS: No. 11696). Hospitals signed a legal contract to regulate their interactions within the network. For patients, treatment in the network was independent of informed consent. The data presented were collected for the purpose of quality assurance and, thus, the identity of the individual patients were anonymous. Therefore, no specific informed consent on individual level was obtained by the patients.
: Not applicable.
: KGH: received lecture honoraria and/or honoraria for consulting from Bayer HealthCare, Biotronik, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, Edwards Lifesciences, EIP Pharma, Medtronic, W. L. Gore, Pfizer, Sanofi-Aventis and research grants from Bayer HealthCare and Sanofi-Aventis.PUH: reports grants from German Ministry of Research and Education, German Research Foundation, European Union, Charité–Universitätsmedizin Berlin, Berlin Chamber of Physicians, German Parkinson Society, University Hospital Würzburg, Robert Koch Institute, German Heart Foundation, University Göttingen (within FIND-AF randomized, supported by an unrestricted research grant to the University Göttingen from Boehringer-Ingelheim), University Hospital Heidelberg (within RASUNOA-prime, supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer, BMS, Boehringer-Ingelheim, Daiichi Sankyo), grants from Charité–Universitätsmedizin Berlin (within Mondafis, supported by an unrestricted research grant to the Charité from Bayer), outside the submitted work.All other authors do not declare any competing interest.